Project Description

Captek Softgel

Prairie Capital Fund V

Location Cerritos, CA
Transaction Type Growth Buyout with Founder and Management
Investment Date February 2011
Exit Date December 2015
Buyer Swander Pace Capital

FDA-compliant manufacturer and distributor of specialty softgel formulations in the nutraceutical sector to the U.S. and global markets

Industry Healthcare

Investment Rationale

  • Attractive industry with strong growth opportunities
  • Experienced, equity incentivized management team
  • Recurring Revenue from diversified, blue chip, branded vitamin and supplement companies
  • Competitive advantage through cGMP compliance
  • Established distribution presence in Asian markets

Value Add

  • Human Capital
  • Sales & Marketing
  • Technology
  • Infrastructure
  • New Products

Working with Prairie was truly a partnership rather than an investor relationship.  Even when things weren’t going smoothly they remained steadfast and supportive and ended every call by asking ‘if there was anything they could do to help.’  Their experience working in the lower middle market was invaluable by providing me with context and advice from their years of experience acquiring businesses from the founders and entrepreneurs and the idiosyncrasies that come with those transactions.  I would love to work with the Prairie team again and hope to someday.

David Wood, Former CEO